Literature DB >> 34708732

Telemedicine in diabetic retinopathy screening in India.

Kim Ramasamy1, Chitaranjan Mishra1, Naresh B Kannan1, P Namperumalsamy1, Sagnik Sen1.   

Abstract

With ever-growing prevalence of diabetes mellitus and its most common microvascular complication diabetic retinopathy (DR) in Indian population, screening for DR early for prevention of development of vision-threatening stages of the disease is becoming increasingly important. Most of the programs in India for DR screening are opportunistic and a universal screening program does not exist. Globally, telemedicine programs have demonstrated accuracy in classification of DR into referable disease, as well as into stages, with accuracies reaching that of human graders, in a cost-effective manner and with sufficient patient satisfaction. In this major review, we have summarized the global experience of telemedicine in DR screening and the way ahead toward planning a national integrated DR screening program based on telemedicine.

Entities:  

Keywords:  Artificial intelligence; diabetes mellitus; diabetic retinopathy; telemedicine; telescreening; vision threatening

Mesh:

Year:  2021        PMID: 34708732      PMCID: PMC8725153          DOI: 10.4103/ijo.IJO_1442_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Diabetes mellitus (DM) prevalence in India has increased from 61.3 million in 2011 to 77 million in 2019; a further 77 million are considered to be prediabetic and is projected to grow to a 101 million by 2030 and 134.2 million by 2045.[123] DM prevalence is higher in low- and middle-income countries (LMICs) due to economic transition of most nations, westernization of the lifestyle and improving longevity. Diabetic retinopathy (DR) is an important microvascular complication seen in people with diabetes (PWD) and can cause significant health hazards in working age group.[4] While the earlier stages of DR, mainly the nonproliferative DR (NPDR) stages, may not cause significant visual impairment, diabetic macular edema (DME) and proliferative DR (PDR) can cause significant vision loss and are together named as vision-threatening DR (VTDR). Left untreated, 26% of people with VTDR are likely to be severely vision impaired in 2 years.[56] The National Diabetes and Diabetic Retinopathy Survey report 2015–2019 estimated the prevalence of DR as 16.9% in the population ≥50 years, and the prevalence of VTDR as 3.6% in India.[7]

Teleophthalmology and DR

The World Health Organiztion had defined teleophthalmology as the delivery of health care services “using information and communication technologies (ICT) for the exchange of diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers.”[8] Teleophthalmology plays a significant role for the screening of many diseases, DR being one of the most important ophthalmic diseases. With strides in the progress in telecommunication, availability of various retinal imaging systems, and integration of offline applications to the smartphones, recent literature has witnessed a surge in studies on telescreening of DR, with impressive sensitivity and specificity for the detection of DR. However, LMICs with regional variations in geopolitics, economy, literature, and accessibility to healthcare face a major challenge in the implementation of a uniform nationwide telescreening model for DR. There are different models of telescreening for DR applicable in different clinical and regional settings. In this review, we summarize the application of teleophthalmology in DR screening across the world and its future importance in LMICs like India, where there is a growing necessity to develop a systematic DR screening program in a cost-effective manner.

Suitability for Screening

According to the WHO, screening should be done for diseases that are an important health problem, have effective treatment which is possible to be delivered early, before the appearance of symptoms, technology for diagnosis is available, screening is feasible and cost effective, and subjects can be followed longitudinally [Table 1].[9] DR fulfils most of these criteria. It has also been shown that screening can reduce the rate of blindness due to DR.[10]
Table 1

WHO screening criteria

Condition should be a significant health problem
There should be an accepted treatment for patients with the disease
Diagnosis and treatment facilities should be available
An early symptomatic or latent stage should be present
There should be a test or examination method
The test should be acceptable to the population
The natural history of the condition should be adequately understood
There should be an agreed policy on patient selection for treatment
Case finding including diagnosis and treatment should be cost effective
Case finding should be a continuous process
WHO screening criteria Conventionally, recommendations for best practices of DR prevention require PWD to visit for ophthalmic follow-ups at least once a year.[11] Annual examinations are recommended for patients under age 30 years starting within 3–5 years after diagnosis of DM. The conventional tools for DR screening include direct ophthalmoscopy, indirect ophthalmoscopy, slit-lamp biomicroscopy, and fundus photography. Traditionally, screening may be either optometrist driven or ophthalmologist driven; however, both methods may no longer be cost effective in India, with the huge emerging burden of disease, more so in rural India. The amount of time to be invested by each ophthalmologist for annual screening of each PWD is projected to rise exponentially, and hence the concept of in-person examinations are gradually being deemed neither sustainable nor practical and may not be enough to meet the minimum standards for preventing vision loss, particularly in the remote locations where there is a scarcity of trained vitreoretinal surgeons. Even in urban areas having good access to healthcare, annual screenings may be missed due to longer waiting lists and booking periods.[1213141516] In this regard, telescreening of the retina for DR may be a disruptive technology.

Challenges in DR Screening

PWD do not visit an ophthalmologist or optometrist till the time they have vision complaints, and by the time they become symptomatic, they would have progressed to the later stages of DR.[17] The high cost of setting up a teleophthalmology program is its biggest deterrent, besides the need of training and maintaining skilled manpower and expensive equipment.[18] Some other major challenges to setting up a telescreening program are attitude to quality of care by ophthalmologists, who are skeptical of a new generation of clinical practices, liability issues, image quality, workflow and management, data security, patient perception, attitudes, etc.[19]

Screening Models

DR screening can be broadly divided into two models, opportunistic screening and systematic screening [Table 2].
Table 2

Different settings for DR screening

Opportunistic screeningSystematic screening
• During the regular visit of the diabetic patient to a health care professional • irregular camp-based screening fundus camera-based imaging with teleconsultation in the physician/endocrinologist’s clinic sporadically when patient asks the treating doctor for the test for detection of DR • mobile van-based screening occurring at an undefined frequency and covering arbitrary geographic locations• Regular DR screening camps in the community • vision centers operating full time with telescreening and consultation from the base eye hospital • fundus camera-based imaging with teleconsultation as a routine part of diabetes evaluation in the physician/endocrinologist’s clinic
Different settings for DR screening

Opportunistic screening

Opportunistic DR screening is done sporadically. The main drawbacks of opportunistic DR screening are that it may not be able to screen all the population at risk and there is a chance that all screening interventions are not standardized and checked for quality assurance. Praveen PA et al.[20] described an affordable opportunistic DR screening model at a tertiary care diabetes clinic by increasing awareness and providing opportunities for DR screening. Muqit et al.[21] have established an opportunistic screening in Bangladesh which detects a significant number of patients with VTDR and visual impairment. Most of the DR screening programs established locally in LMICs are opportunistic.

Systematic screening

Systematic DR screening involves active identification of the population at risk in a quality-assured manner and targets the entire population at risk. All the at risk population are given prior information about the screening program. The UK NHS Diabetic Eye Screening Programme is a successful implementation of a systematic DR screening program.[22]

Devices for Telescreening

The typical retinal imaging devices used for the screening of DR include color fundus photography (CFP) and direct and indirect ophthalmoscopy. Due to the noninvasiveness, automation, portability, and high sensitivity and specificity, these devices have made successful miniaturization of the point of care diagnosis of DR. The available devices for screening of DR can be divided into table-top and smartphone-based devices.

Table-top/traditional fundus cameras

Although the modified Airlie house 30° seven-field CFP, encompassing a 75° fundus viewing angle is the gold standard of fundus imaging for the detection of DR, it is practically not possible for screening purposes, because it is laborious, time consuming, and needs a trained photographer.[23] The different table-top fundus cameras[24252627] in current use are summarized in Table 3.
Table 3

Commercially available fundus cameras

Table-top/traditional fundus camerasSmartphone-based fundus cameras
45-degree single field  Sensitivity and specificity of referable DR 78 and 86%, respectively  Used in the UK DR screening program  Nonmydriatic camera  Minimum pixel needed -30 pixel per degree, with 45° width and 40° heightThe OphthalmicDocs Fundus D-eye system Portable Eye Examination Kit (PEEK) device iExaminer (Welch Allyn) DigiSight’s mobile ophthalmic camera (Paxos Scope) Ocular cellscope Volk iNview MII RetCam (Make In India Retinal Camera) Smart i-RxCam™ (VisionQuest Biomedical, LLC) Remidio nonmydriatic Fundus on Phone (FOP) device (Remidio Innovative Solutions, Bangalore, India) EyeSelfie (MIT Media Lab)
45-degree 2-field  Sensitivity and specificity of referable DR 96% and 89, respectively  The FDA approved AI-based DR screening device uses two 45-degree CFP[28]
45-degree 3-field  Sensitivity and specificity of referable DR 92 and 96%, respectively
Ultra-wide field (UWF) CFP  Fundus imaging with 100 degrees or more field[29]  Anatomical classification of UWF defined as the retinal image beyond the vortex vein ampullae in all the four quadrants obtained in a single capture[30] • Optos (Optos plc, Scotland)  Assesses 200-degree retinal field using confocal scanning laser technology (cSLO) with three wavelengths; blue (488 nm), green (532 nm) , and red (635 nm)  Can detect peripheral features of DR in 20% of the eyes without any detectable DR using conventional CFP  33-41% of the Optos UWF may have predominantly peripheral (PPL) distribution of DR lesions[3132] • Clarus (Carl Zeiss Meditec, US)  This uses LED-based cSLO technology and captures a single field of 133°, with montage reaching up to 200 degrees • Heidelberg multicolor scanning laser imaging  A special lens can be mounted onto the OCT/SLO camera, providing a 105° pseudocolor image • Leftvue Eidon  Combines a cSLO technique with a confocal white light imaging to obtain true color CFP covering 60° per image • Mirante (Nidek Inc. Japan)  Field of a view of 163° and has options of multimodal imaging
The limitations of UWF imaging include high cost, limited portability, and need of good patient cooperation during imaging. Recently several smartphone-based imaging systems have come up, which are easier to use, need much lesser investment and most importantly, are portable and can be used easily by the patients
Commercially available fundus cameras

Smartphone-based fundus cameras

Smartphones are universally available today at reasonable costs, and with increased mobile connectivity through internet may prove as very cost-effective alternatives to conventional fundus cameras for screening programs.[333435363738394041424344] Some of the common smartphone-based devices are tabulated in Table 3. Two devices which have been designed and manufactured in India are the MII RetCam and the Remidio Fundus on Phone (FOP) device. The MII RetCam is capable of visualizing even the peripheral regions of the retina up to the pars plana.[45] The Remidio FOP device can capture high-resolution images of the retina, uses an annular illumination light source, and can be attached to a smartphone. The FOP smartphone device has been used in a validation study of an offline AI algorithm for a community-based DR screening program in West India, with a sensitivity of 100% for detection of referable DR.[46] The FOP device has lesser ungradable images as compared to routine tabletop fundus cameras.[47] The Remidio FOP NM-10 has been approved by the FDA as a telemedicine-friendly, portable smartphone-based imaging device. Smartphone ophthalmoscopy can perform satisfactorily in detecting DR as compared to conventional photography, with the highest diagnostic accuracy for PDR (92%), followed by referable DR (91%).[48] Sensitivity of smartphone-based screening is higher for treatment requiring stages of DR.[49] Hence, this may be a better alternative in DR screening programs in LMICs by reducing total costs of implementation and need to be tested more in the community settings. However, these devices require mydriasis for image capture.

Mydriasis and its Role in Imaging

Digital imaging programs using nonmydriatic cameras may have a higher proportion of ungradable images and may lead to higher chances of unnecessary referrals, reducing the cost-effectiveness of the program.[1450,] Mydriasis seems to reduce this risk.[51] Hence, mydriasis may be considered in subjects with less than 6/12 visual acuity or more than 60 years of age.[5253] Some studies have observed that nonmydriatic images may be sufficient for DR and DME detection, and a three-field 45° image may be superior over a single-field image.[2554] However, mydriasis status alone may not significantly affect the detection sensitivity and patients themselves also prefer nonmydriatic retinal photography.[55] In this regard, ultrawide field (UWF) imaging technology may help obtain images of better field of view without mydriasis and reduce the proportion of ungradable images. UWF platforms may have higher overall DR and VTDR detection rate and referral rate compared with nonmydriatic multifield photography.[56] However, UWF devices may need a high-resource setting and further validation against American Telemedicine Association (ATA) category standards.

International Guidelines for Telemedicine in Ophthalmology

The reference standard for all telemedicine programs are the ETDRS 30° stereo seven-standard fields, color, 35 mm slides. However, there is no unanimity on the best digital photography protocol which can replace ETDRS photographs in telescreening programs.[5758] Therefore, the ATA and Ocular Telehealth Special Interest Group have defined different levels of validation for the purpose of standardization of digital photography used in telescreening.[59] The diagnostic accuracy of digital imaging used must be validated and adhere to standards of Digital Imaging and Communication in Medicines (DICOM).[60] Table 4 summarizes the different categories of validation.
Table 4

Levels of validation as recommended by the ATA-OTSIG

Levels of validationApplication
Category 1Screen for the presence or absence of greater than minimal DR
Category 2Screen for patients with and without VTDR
Category 3To identify ETDRS-defined levels of NPDR (mild, moderate, or severe), PDR (early and high risk), and DME
Category 4A system that has been shown to match or exceed the ability of ETDRS photographs to identify lesions of DR
Levels of validation as recommended by the ATA-OTSIG

Global Experience in Teleophthalmology Programs

Over the past two decades, several studies from various countries have shown successful implementation and running of telescreening programs from the patient, caregiver, and administration's point of view. Although the results of conventional DR screening by optometrists and nonclinical healthcare workers may be marginally lower than trained retina specialists or ophthalmologists, studies using telemedicine with nonmydriatic cameras have shown comparable results with conventional screening.[6162636465666768] Some studies have shown that primary care physicians can also reliably evaluate fundus images after proper training.[6970] An example of a very successful national DR telescreening program is that of the UK, which has underlined the importance or monitoring of DR along with the overall glycemic status of patients, so much so that DR has ceased to be a leading cause of blindness in England and Wales.[71] The Teleophthalmological Services Citizen Centered Application or TOSCA provides DR telescreening in Europe and has demonstrated that retinal images can be electronically transmitted easily to distant centers for remote grading.[72] Davis et al.[73] performed a randomized controlled trial comparing the effectiveness of telescreening program with the usual care, using a nonmydriatic fundus camera located in a rural primary care practice. The study observed that by having the ophthalmologist grade retinal images sitting at the university center along with video conferencing with patients, the participation rate of patients in the novel screening program had increased six times, compared to conventional scheduled hospital examination. A summary of programs in various countries in use, according to the levels given by ATA, is given in Table 5.[74]
Table 5

Established DR screening programs in Western countries

ATA categories

1234
DR gradingNo or minimal DRNo DRNo DRNo DR
Mild DRMild DR
Mild or moderate DRModerate DRModerate DR
More than minimal DRSevere NPDRSevere NPDR
Early PDREarly PDR
Vision threatening DR or DMEHigh risk DRHigh risk DR
DMEDME
FunctionsScreeningScreening and risk stratificationScreening, risk stratification, treatment recommendationExceeds ETDRS seven field photos, Can replace ETDRS photos in programs
ProgramsOphdiat (Paris, France)[75]EyeCheck (Netherlands)[76]Joslin Vision Netwrok (Massachusetts, USA)[77]None
EyePacs (CA, USA)[7879]NHS Diabetic Eye Screening program (UK)[5280818283]University of Alberta, (Canada)[84]
Digiscope (Maryland, USA)[63] Aravind Teleophthalmology network (India)[85]
Established DR screening programs in Western countries Most of these programs are primary care office-based and employs trained nurses or nonmedical staff for capturing the fundus images. Grading is done by ophthalmologists, optometrists, or nonophthalmic-trained readers. The programs commonly use two or three nonstereo photos. Scottish DR screening program uses single-field 45-degree macula centered images. A single-field image may be sufficient for detection and referral of DR patients in the community and is relatively less time consuming.[86] All programs, except the UK and Canada use nonmydriatic cameras. The various retinal findings in the fundus image taken at the time of screening may be confirmed when the patient presents at the main center for examination.[87] Apart from the detection of DR grades, telescreening may also be quite sensitive in the detection of DME with high accuracy.[17] Teleophthalmology screening may reduce unnecessary hospital visits by patients, and hence a greater number of patients may be effectively screened overall, by reducing the pressures over tertiary care centers. Moreover, the screening frequency of patients may also be smoothly increased, since the screening is being performed at a remote site.[88] A metanalysis of 33 international telescreening studies on DR has observed that the screening programs may be 87% sensitive and 91% specific for the detection of any retinopathy.[19] Moreover, the sensitivity and specificity of detection of mild and moderate NPDR are also significantly high.[89] The latest country to implement a nationwide DR screening program is Singapore in the form of the Singapore Integrated DR Program (SiDRP) based on telemedicine and centralized reading centers.[90] This program has also shown comparative effectiveness in terms of health outcomes and cost. A study from South India comparing the effectiveness of an ATA category 1 DR screening program with universal conventional screening found that although the total number of DR cases detected by conventional screening might be more, the proportionate yield of DR is higher with telescreening, taking into account actual hospital attendance.[91] The attendance of actual referred patients was proportionately higher in the telescreening group. The Aravind Teleophthalmology Network utilizes vision centers having ophthalmic technicians and DR camps to screen patients in remote areas. Photographs are sent to physician graders in central grading centers for grading and patients are referred to higher centers if needed.[91] The responsibility of image acquisition is very important for all programs and depends on quality assurance protocols, which have been put in place to improve and maintain the quality of images taken, and reduce the rate of ungradable images.[92]

Cost Effectiveness of Telescreening Programs

The parameters on which a successful teleophthalmology program can run are diagnostic accuracy and cost effectiveness.[18] Although 50–90% of population may need some form of DR screening, only about 10% will end up requiring management for vision loss.[93] Hence, in-person examinations need to be reduced with the help of teleophthalmology programs using a universal screening model. Although there may be an initial requirement of substantial capital investment for implementation, the overall final cost benefit is larger than conventional screening programs.[89] The cost effectiveness of DR screening programs has been evaluated internationally, especially for detection of VTDR.[9495969798]

Telescreening setting

Mobile community-based screening services help increase recruitment and community participation.[99] Moreover, the effectiveness of the program increases when DR screening is combined with screening for other diseases the population may be at risk of.[100] Preventive programs for PWD produce significant savings; hence, they are highly cost effective for society in general, especially DR being the most cost effective and cost saving.[101102103] The costs of grading in a reading center are lower, and higher specificity of the DR grades means lesser unnecessary referrals to the base hospital. The SiDRP reported cost savings of $173 per patient compared to the preexisting family physician driven model.[92] Although from a public health view, ophthalmoscopy appears less costly due to requirement of lower capital investment, from a global perspective, teleophthalmology is more efficient, since it reduces travel and time cost and loss of income of patients.[104] Finally, telescreening may provide better cost benefits in the LMIC countries.[105106]

Factors driving costs

Populations screened at a younger age, having higher HBA1c or having higher transportation costs have the most benefit from telescreening.[107108] The cost effectiveness also depends on the disease burden and population size, especially at a higher workload.[108] Another important factor guiding the cost is the screening interval, which may be individualized based on the risk level of patients.[109110111] PWD with no DR have a relatively low risk of developing VTDR over 2 years, irrespective of one-field or two-field fundus screenings.[112113] By stratifying patients into low-risk and high-risk groups and subsequent adaptation of individualized screening intervals, cost reduction can be achieved.[114115] A rural teleophthalmology screening program in India found that the program was cost-effective ($1320 per QALY (Quality adjusted life years)) as compared to no screening at all.[109] The study also evaluated that a biannual screening may be more cost effective than annual screening (>$3183 per QALY).

Artificial Intelligence and Role in Telescreening

Human grading being a subjective task is prone to mislabeling due to several factors like exhaustion, misidentification, and fatigue and may lead to uncertainty of the results. Moreover, there is no gold standard for the perfect grading. Automated analysis can bring objectivity and repeatability to DR screening and grading and may help reduce the burden of human grading. Deep learning systems (DLS) have already shown good results in multiple medical diseases. Automated algorithms for DR detection have shown good accuracy for the presence of moderate and severe DR as well as DME. Multiple Indian eye centers are involved in development and validation of artificial intelligence-based algorithms in DR.[116117118] Recently, a Singapore-based DLS has been noted to have comparable diagnostic accuracy to human graders.[119] A semiautomated DLS model involving a secondary human assessment may be the most cost-effective model [Fig.1].[120] A fully automated system may suffer from false positive data, leading to unnecessary specialist visits and increasing costs.
Figure 1

(a) Conventional teleophthalmology screening model. (b) Semiautomated AI based screening model. (c) Fully automated AI-based screening model

(a) Conventional teleophthalmology screening model. (b) Semiautomated AI based screening model. (c) Fully automated AI-based screening model The USFDA has recently authorized IDx-DR, an autonomous AI system, for use in adults aged 22 years or older, for detection of DR stages more than mild DR and DME, based on multilayer convolutional neural networks.[28] It has a sensitivity of 87.2%, specificity of 90.7%, and an imageability rate of 96.1%, and it has performed superiorly to all high-quality predetermined standards.

Model Teleophthalmology Practice Guidelines

The design, planning, programming, implementation, and sustenance of telescreening programs need cooperation among public and private organizations and national and international agencies.[121] Clearly defined mission, vision, and guiding principles are required for effective running of the program. Generally, all programs should target to improve the access and availability of eye health via telescreening, reduce costs of healthcare, and enhance the efficacy of management of DR. The programs must be developed and deployed in a safe manner and should be closely monitored so that they meet the overall standards of care. Patients need to be explained that the screening is not a replacement of existing hospital/center-based facilities. All programs must undergo an internal examination for ATA category validation determination to ascertain performance standards and program goals. The program's validation category may impact the operational features and business model of the program.

Personnel specifications

- Human resource allocation for specifically defined function in the telescreening program is required for efficient running. - Image acquisition personnel - Medical supervisor (ophthalmologist or optometrist) - Image grading personnel - Information technology personnel

Technical guidelines

- Equipment under the telescreening program need to conform to the national drugs and devices regulating agency. These include: - Image capturing devices (cameras, computers) - Image transmission and storage facilities - Image enhancement technologies - Data management, storage (PACS, DICOM) and data security

Administrative guidelines

- Legal requirements for accreditation, insurance, patient consent - Quality control and maintenance of professional standards - Customer support

Operational standards guidelines

- Data registry - Training of manpower - Management of referral of patients - Non-attendance rates - Re-call screened patients

Initiatives of Teleophthalmological Society of India

The Teleophthalmology Society of India (TOSI) was established with an aim to promote research and training toward development of teleophthalmology practices, advocacy, organization of symposia, seminars, and courses for training of personnel. In the coming days, TOSI is to play an instrumental role in the process of developing and implementation of teleophthalmology DR screening by developing guidelines, training programs, and promoting telescreening among all the stakeholders, especially ophthalmologists, general physicians, endocrinologists, image graders, technicians, etc.

Telescreening Management and Diabetic Retinopathy Registry

To ensure a proper running of a DR telescreening program in India, the health management information systems in the country need to ensure the incorporation of infrastructure and equipment. Insurance providers like the Ayushman Bharat can provide for the financing and reimbursement of costs. All patients screened in the program need to be registered with an identification number with all their clinical data stored and backed up. The retinal images are to be transmitted digitally in a picture archiving and communication systems format and stored and transferred by DICOM. These registries may be set up as public–private partnerships.[122]

Patient Satisfaction Related to Telescreening of DR

Telescreening of DR is gaining more popularity among patients. In a study done in Kenya, PWD found that the telescreening method was more convenient than the conventional clinical detection of DR.[123] In a prospective study of telescreening of DR using a nonmydriatic camera, 98.6% of the patients found the telescreening method acceptable, 95.1% wanted their next DR screening to be through teleconsultation and 91.2% stated it would increase their compliance to annual screening.[16]

Conclusion

With an ever-increasing incidence of diabetes in LMICs like India, the economic cost of diabetes related complications especially DR will be very high. The national DR screening teleophthalmology program in the United Kingdom is a very good example that the developing countries can follow and integrate DR telescreening in the already established national programs like NPCB, NPCDCS, etc. All the abovementioned opportunities should be used to implement DR screening in National noncommunicable diseases programs. A multidisciplinary collaborative approach must be undertaken in order to improve retinopathy detection in the early stage of the disease. A primary care physician/an endocrinologist or PHCs can be the first point of contact for the PWD, and this strategy will ensure the probability of having a retinal screening. Therefore, if primary care or multispecialty clinics are equipped with fundus cameras, especially in areas without access to eye care specialists, the coverage of screening would increase. With the advent of AI, this telescreening process can very well be accelerated as the dependency on human resources for grading will be greatly reduced. Moreover, AI will bring in much better consistency and will be available round the clock. With improvements in AI algorithms, this process will improve not only screening for DR but also early identification of many other diseases affecting the retina. Automated screening systems are not limited to DR and may be applicable for other conditions, such as age-related macular degeneration and glaucoma, where earlier detection would likely improve clinical outcome. Today many such algorithms are available. Rigorous validation testing of all such algorithms should be done to determine suitability for clinical implementation.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  105 in total

1.  The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy: response to Ahmed et al.

Authors:  Rajiv Raman; Padmaja Kumari Rani; Tarun Sharma
Journal:  Diabetes Care       Date:  2007-05       Impact factor: 19.112

Review 2.  Telemedicine in diabetic retinopathy screening.

Authors:  Ingrid E Zimmer-Galler; Ran Zeimer
Journal:  Int Ophthalmol Clin       Date:  2009

3.  Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  S Vijan; T P Hofer; R A Hayward
Journal:  JAMA       Date:  2000-02-16       Impact factor: 56.272

4.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

5.  Comparison between an ophthalmic optician and an ophthalmologist in screening for diabetic retinopathy.

Authors:  C J Hammond; J Shackleton; D W Flanagan; J Herrtage; J Wade
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

Review 6.  Telehealth practice recommendations for diabetic retinopathy.

Authors:  Jerry Cavallerano; Mary G Lawrence; Ingrid Zimmer-Galler; Wendell Bauman; Sven Bursell; W Kelley Gardner; Mark Horton; Lloyd Hildebrand; Jay Federman; Lisa Carnahan; Peter Kuzmak; John M Peters; Adam Darkins; Jehanara Ahmed; Lloyd M Aiello; Lloyd P Aiello; Gary Buck; Ying Ling Cheng; Denise Cunningham; Eric Goodall; Ned Hope; Eugene Huang; Larry Hubbard; Mark Janczewski; J W L Lewis; Hiro Matsuzaki; Francis L McVeigh; Jordana Motzno; Diane Parker-Taillon; Robert Read; Peter Soliz; Bernard Szirth; Robert A Vigersky; Thomas Ward
Journal:  Telemed J E Health       Date:  2004       Impact factor: 3.536

7.  Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study.

Authors:  Ferdinando Carlo Sasso; Pia Clara Pafundi; Aldo Gelso; Valeria Bono; Ciro Costagliola; Raffaele Marfella; Celestino Sardu; Luca Rinaldi; Raffaele Galiero; Carlo Acierno; Chiara de Sio; Luigi Elio Adinolfi
Journal:  Diabetes Metab Res Rev       Date:  2019-01-07       Impact factor: 4.876

8.  Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

Review 9.  Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review.

Authors:  Beau J Fenner; Raymond L M Wong; Wai-Ching Lam; Gavin S W Tan; Gemmy C M Cheung
Journal:  Ophthalmol Ther       Date:  2018-11-10

10.  Screening model for diabetic retinopathy among patients with type 1 diabetes attending a tertiary care setting in India.

Authors:  Pradeep A Praveen; Pradeep Venkatesh; Nikhil Tandon
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

View more
  2 in total

1.  Tele-Ophthalmology Versus Face-to-Face Retinal Consultation for Assessment of Diabetic Retinopathy in Diabetes Care Centers in India: A Multicenter Cross-Sectional Study.

Authors:  Ramachandran Rajalakshmi; Ganesan UmaSankari; Vijayaraghavan Prathiba; Ranjit Mohan Anjana; Ranjit Unnikrishnan; Ulagamathesan Venkatesan; Saravanan JebaRani; Coimbatore Subramanian Shanthirani; Sobha Sivaprasad; Viswanathan Mohan
Journal:  Diabetes Technol Ther       Date:  2022-04-13       Impact factor: 7.337

2.  [Assessment of a teleophthalmology program for the prevention of diabetes blindness in a rural area of Argentina.]

Authors:  Tomas Ortiz-Basso; Paula Verónica Gomez; Analia Boffelli; Ariel Paladini
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.